Altre lingue CombiGene AB

Azioni

COMBI

SE0016101935

Mercato chiuso - Nasdaq Stockholm Altri mercati azionari 17:18:43 24/04/2024			Variaz. 5gg	Var. 1 gen.
3,8 ^SEK	0,00%		-1,30%	+41,26%

13/03	Il progetto sull'epilessia CG01 di CombiGene riceve il brevetto in due nuovi Paesi	CI
21/02	Orphazyme A/S (CPSE:ORPHA) ha acquisito un'ulteriore partecipazione di minoranza sconosciuta in CombiGene AB (publ) (OM:COMBI).	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Notice of Annual General Meeting in CombiGene AB (publ)	18/04
BioStock: CombiGene's CEO comments on the patent approvals in Australia and India	20/03
CombiGene’s epilepsy project CG01 has been granted patent in two new countries	13/03
CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries	13/03
BioStock: Comments from Orphazyme on the investment in CombiGene	04/03
The Danish company Orphazyme has acquired 10% of the shares in CombiGene	21/02
Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI).	21/02
Year-end report January-December 2023 CombiGene AB (Publ)	16/02
CombiGene AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
BioStock: CombiGene comments on the discontinued CGT2 project	02/02
CombiGene discontinues the preclinical development of the lipodystrophy project CGT2	01/02
CombiGene: "We continue to believe in the epilepsy project CG01"	16/01
CombiGene has regained the global rights to the epilepsy project CG01	13/01
BioStock: CombiGene comments on Eurostars funding	22/12
Eurostars contributes SEK 8,7 million to the financing of the COZY01 pain project	20/12
New issue of CombiGenes, no 5 2023	27/11
BioStock: CombiGene focuses on the pain project	15/11
Interim report January – September 2023 for CombiGene AB (publ)	10/11
CombiGene AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
CombiGene Taps Charles River Laboratories as Clinical Research Partner for Pain Project	01/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CombiGene AB

Azioni

COMBI

SE0016101935

Altre lingue

Filtri